Rhonda Rhyne

Rhonda has more than 25 years of experience in life sciences with both public and private industry companies, as well as experience as a clinical pharmacist. She is presently director, president, and CEO of Prevencio, Inc., a leading pioneer in the development of a multiplex cardiac proteomics blood biomarker test that assists ER physicians and cardiologists in assessing obstructive heart disease. Rhonda also serves as a board director for OtoNexus Medical Technologies, La Jolla Institute for Allergy & Immunology, and previously Washington Biotechnology and Biomedical Association (WBBA). She earned an MBA from UCLA and a bachelor’s degree in pharmacy from Washington State University.